Yuxi Wang

发表

Dual-target inhibitors of poly (ADP-ribose) polymerase-1 for cancer therapy: Advances, challenges, and opportunities.

L. Ouyang, Xinyue Hu, Jifa Zhang, 2021, European journal of medicinal chemistry.

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance

Yuxi Wang, Fangyi Long, Hong Lin, 2022, Molecular Cancer.

Emerging strategies to overcome resistance to third-generation EGFR inhibitors

L. Ouyang, Guan Wang, Jifa Zhang, 2022, Journal of Hematology & Oncology.

Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives.

L. Ouyang, Jifa Zhang, Ya Zhang, 2022, European journal of medicinal chemistry.

Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2022, Journal of medicinal chemistry.

Discovery of 4-Hydroxyquinazoline Derivatives as Small Molecular BET/PARP1 Inhibitors That Induce Defective Homologous Recombination and Lead to Synthetic Lethality for Triple-Negative Breast Cancer Therapy.

L. Ouyang, Jie Liu, Jifa Zhang, 2022, Journal of medicinal chemistry.

Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.

L. Ouyang, Huijing Wang, Jifa Zhang, 2022, European journal of medicinal chemistry.

Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development.

L. Ouyang, Fengbo Wu, Jifa Zhang, 2022, Journal of medicinal chemistry.

Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.

L. Ouyang, Jifa Zhang, Jiaxing Wang, 2022, Journal of medicinal chemistry.

Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy.

Zelin Hu, Jifa Zhang, Ya Zhang, 2022, European journal of medicinal chemistry.

Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2022, European journal of medicinal chemistry.

Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2022, Journal of medicinal chemistry.

A circular RNA, circPTPN14, increases MYC transcription by interacting with FUBP1 and exacerbates renal fibrosis

Ying Zhang, Weiqiang Lin, Xiaobo Shen, 2022, Cellular and Molecular Life Sciences.

Porcine sapelovirus 2A protein induces mitochondrial-dependent apoptosis

Zhenhai Chen, Yuxi Wang, Kaichuang Shi, 2022, Frontiers in Immunology.

Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2022, European journal of medicinal chemistry.

Outcomes of Kidney Transplantation Using Organs From A Donor Infected with Carbapenem-Resistant Klebsiella Pneumoniae in A Chinese Hospital: A Molecular Epidemiological Study

Yichun Gong, Peihan Li, Peng Li, 2020 .

Targeting ferroptosis: Paving new roads for drug design and discovery.

Lele Zhang, Yizhe Li, Jifa Zhang, 2022, European journal of medicinal chemistry.

Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.

Y. Liu, Jifa Zhang, Hao Chen, 2023, European journal of medicinal chemistry.

Current progress and novel strategies that target CDK12 for drug discovery.

Peng-Zhen Lei, Jifa Zhang, Jiaxing Wang, 2022, European journal of medicinal chemistry.

CD25: A potential tumor therapeutic target

Ya Zhang, Jiaxing Wang, Yuxi Wang, 2022, International journal of cancer.

Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects.

S. Cao, Jifa Zhang, Jiaxing Wang, 2023, Journal of medicinal chemistry.

Targeting EZH2 for cancer therapy: From current progress to novel strategies.

L. Ouyang, Souvik Banerjee, Jifa Zhang, 2022, European journal of medicinal chemistry.

DYRK1A inhibitors for disease therapy: Current status and perspectives.

Jifa Zhang, Jiaxing Wang, Hao Chen, 2021, European journal of medicinal chemistry.

Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy.

L. Ouyang, Guan Wang, Weimin Li, 2022, Journal of medicinal chemistry.

Epidemiology of carbapenem-resistant Klebsiella pneumoniae bloodstream infections after renal transplantation from donation after cardiac death in a Chinese hospital: a case series analysis

Lei Cui, Qiwen Yang, H. Lei, 2018, Antimicrobial Resistance & Infection Control.

Gr upSM The Clinical Characteristics , Imaging Findings , and Treatments for the Severe Infection of Klebsiella Pneumonia in ICU : A Case Series Report

Jiaxing Wang, Yuxi Wang, Cheng Xu, 2017 .

Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives.

Peng-Zhen Lei, Jifa Zhang, Jiaxing Wang, 2023, European journal of medicinal chemistry.

Targeting epigenetic modifications in Parkinson's disease therapy

L. Ouyang, Guan Wang, Jifa Zhang, 2023, Medicinal research reviews.

Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics.

L. Ouyang, Xinyue Hu, Jifa Zhang, 2023, Journal of medicinal chemistry.

X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma.

Zichao Yang, Jianjun Chen, Yuxi Wang, 2023, Journal of medicinal chemistry.

Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challenges.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2023, European journal of medicinal chemistry.

Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2023, European journal of medicinal chemistry.

Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects.

Jifa Zhang, Jiaxing Wang, Yuxi Wang, 2023, European journal of medicinal chemistry.

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors.

Jiaxing Wang, Yuxi Wang, Kunyu Shi, 2023, European journal of medicinal chemistry.

ASSESSMENT OF IMMUNOGENICITY OF CP8, CLFA-FnBPB AND CP8-CLFA-FnBPB ANTIGENS

Yong-qing Hao, shuyi wang, Yuxi Wang, 2013 .